Acneiform rash due to epidermal growth factor receptor inhibitors: High-level laser therapy as an innovative approach

Lasers in Medical Science

Volumn 27, Issue 5, 2012, Pages 1085-1090

  Gobbo, M ^a   Ottaviani, G ^a   Mustacchi, G ^a   Di Lenarda, R ^a   Biasotto, M ^a  

^a UNIVERSITY OF TRIESTE   (Italy)

Author keywords

Acneiform rash; Cetuximab; Diode laser; Epidermal growth factor receptor inhibitors; High level laser therapy

Indexed keywords

CETUXIMAB;

ACNE; ARTICLE; CASE REPORT; COLORECTAL CANCER; EYE INJURY; FOLLOW UP; HEAD AND NECK CANCER; HIGH LEVEL LASER THERAPY; HUMAN; PHOTOTHERAPY; PRIORITY JOURNAL; PROTECTIVE EQUIPMENT; QUESTIONNAIRE; TREATMENT DURATION; TREATMENT OUTCOME; VISUAL ANALOG SCALE; WOUND HEALING;

ACNEIFORM ERUPTIONS; ANTIBODIES, MONOCLONAL; COLORECTAL NEOPLASMS; DRUG ERUPTIONS; HEAD AND NECK NEOPLASMS; HUMANS; LASER THERAPY, LOW-LEVEL; LASERS, SEMICONDUCTOR; RECEPTOR, EPIDERMAL GROWTH FACTOR;

EID: 84866735500     PISSN: 02688921     EISSN: 1435604X     Source Type: Journal    
DOI: 10.1007/s10103-011-1029-4     Document Type: Article

References (34)

1. Fakih M, Vincent M (2010) Adverse events associated with anti-EGFR therapies for the treatment of metastatic colorectal cancer. Curr Oncol 17(1):18-30
2. Kuhnt T, Sandner A, Wendt T, Engenhart-Cabillic R, Lammering G, Flentje M, Grabenbauer G, Schreiber A, Pirnasch A, Dunst J. Phase I trial of dose-escalated cisplatin with concomitant cetuximab and hyperfractionated- accelerated radiotherapy in locally advanced squamous cell carcinoma of the head and neck. Ann Oncol. 2010 Apr. 28
3. Karapetis CS, Khambata-Ford S, Jonker DJ, O'Callaghan CJ, Tu D, Tebbutt NC, Simes RJ, Chalchal H, Shapiro JD, Robitaille S, Price TJ, Shepherd L, Au HJ, Langer C, Moore MJ, Zalcberg JR (2008) K-ras mutations and benefit from cetuximab in advanced colorectal cancer. N Engl J Med 359(17):1757-1765
4. Birnbaum A, Dipetrillo T, Rathore R, Anderson E, Wanebo H, Puthwala Y, Joyce D, Safran H, Henderson D, Kennedy T, Ready N, Sio TT (2010) Cetuximab, paclitaxel, carboplatin, and radiation for head and neck cancer: a toxicity analysis. Am J Clin Oncol 33(2):144-147
5. Giro C, Berger B, Bölke E, Ciernik IF, Duprez F, Locati L, Maillard S, Ozsahin M, Pfeffer R, Robertson AG, Langendijk JA, Budach W (2009) High rate of severe radiation dermatitis during radiation therapy with concurrent cetuximab in head and neck cancer: results of a survey in EORTC institutes. Radiother Oncol 90(2):166-171
6. Guhl G, González-de Arriba A, Daudén E (2006) Epidermal growth factor receptor inhibitors side effects. Actas Dermosifiliogr 97(5):296-310
7. Mascia F, Cataisson C, Lee TC, Threadgill D, Mariani V, Amerio P, Chandrasekhara C, Souto-Adeva G, Girolomoni G, Yuspa SH, Pastore S (2010) EGFR regulates the expression of keratinocytederived granulocyte/macrophage colony-stimulating factor in vitro and in vivo. J Invest Dermatol 130(3):682-693
8. Gencoglan G, Ceylan C (2007) Two cases of acneiform eruption induced by inhibitor of epidermal growth factor receptor. Skin Pharmacol Physiol 20(5):260-262
9. Tjin-A-ton ML, van Montfrans C, Koldenhof JJ, Sigurdsson V, Voest EE, Witteveen PO (2007) Skin eruptions as an adverse reaction to epidermal growth-factor receptor inhibitors. Ned Tijdschr Geneeskd 151(17):945-952
10. Bragg J, Pomeranz MK (2007) Papulopustular drug eruption due to an epidermal growth factor receptor inhibitors, erlotinib and cetuximab. Dermatol Online J 13(1):1
11. Heidary N, Naik H, Burgin S (2008) Chemotherapeutic agents and the skin: an update. J Am Acad Dermatol 58(4):545-570
12. Lacouture ME, Melosky BL (2007) Cutaneous reactions to anticancer agents targeting the epidermal growth factor receptor: a dermatology-oncology perspective. Skin Therapy Lett 12(6):1-5
13. Pryor DI, Porceddu SV, Burmeister BH, Guminski A, Thomson DB, Shepherdson K, Poulsen M (2009) Enhanced toxicity with concurrent cetuximab and radiotherapy in head and neck cancer. Radiother Oncol 90(2):172-176
14. Tomková H, Kohoutek M, Zábojníková M, Pospíšková M, Ostøížková L, Gharibyar M. Cetuximab-induced cutaneous toxicity. J Eur Acad Dermatol Venereol. 2009 Nov. 18
15. Wollenberg A, Kroth J, Hauschild A, Dirschka T (2010) Cutaneous side effects of EGFR inhibitors-appearance and management. Dtsch Med Wochenschr 135(4):149-154
16. Eaby B, Culkin A, Lacouture ME (2008) An interdisciplinary consensus on managing skin reactions associated with human epidermal growth factor receptor inhibitors. Clin J Oncol Nurs 12(2):283-290
17. Bernier J, Bonner J, Vermorken JB, Bensadoun RJ, Dummer R, Giralt J, Kornek G, Hartley A, Mesia R, Robert C, Segaert S, Ang KK (2008) Consensus guidelines for the management of radiation dermatitis and coexisting acne-like rash in patients receiving radiotherapy plus EGFR inhibitors for the treatment of squamous cell carcinoma of the head and neck. Ann Oncol 19(1):142-149
18. Wollenberg A, Moosmann N, Kroth J, Heinemann V, Klein E (2007) Therapy of severe cetuximab-induced acneiform eruptions with oral retinoid, topical antibiotic and topical corticosteroid. Hautarzt 58(7):615-618
19. Roé E, García Muret MP, Marcuello E, Capdevila J, Pallarés C, Alomar A (2006) Description and management of cutaneous side effects during cetuximab or erlotinib treatments: a prospective study of 30 patients. J Am Acad Dermatol 55(3):429-437
20. Pinto C, Barone CA, Girolomoni G, Russi EG, Merlano MC, Ferrari D, Maiello E (2011) Management of skin toxicity associated with cetuximab treatment in combination with chemotherapy or radiotherapy. Oncologist 16(2):228-238
21. Waris W, Naik S, Idrees I, Taha H, Camosino L, Mehrishi A, Saif MW (2009) Severe cutaneous reaction to cetuximab with possible association with the use of over-the-counter skin care products in a patient with oropharyngeal cancer. Cutan Ocul Toxicol 28(1):41-44
22. Radovics N, Kornek G, Thalhammer F et al (2010) Analysis of the effects of vitamin K1 cream on cetuximab-induced acne-like rash. J Clin Oncol 28:19671
23. Santiago F, Gonçalo M, Reis JP, Figueiredo A (2011) Adverse cutaneous reactions to epidermal growth factor receptor inhibitors: a study of 14 patients. An Bras Dermatol 86(3):483-490
24. Karu TI, Afanas'eva NI (1995) Cytochrome c oxidase as the primary photoacceptor upon laser exposure of cultured cells to visible and near IR-range light. Dokl Akad Nauk 342(5):693-695
25. Lopez M, Gebbia N, Cascinu S, Marchetti P. Oncologia medica pratica 2010;3a edizione; Società Editrice Universo; 836-7;1045;1308;1343-1347
26. Balagula Y, Wu S, Su X, Lacouture ME. The effect of cytotoxic chemotherapy on the risk of high-grade acneiform rash to cetuximab in cancer patients: a meta-analysis. Ann Oncol. 2011 Mar. 14.
27. Aykol G, Baser U, Maden I, Kazak Z, Onan U, Tanrikulu-Kucuk S, Ademoglu E, Issever H, Yalcin F (2011) The effect of low-level laser therapy as an adjunct to non-surgical periodontal treatment. J Periodontol 82(3):481-488
28. Kujawa J, Zavodnik L, Zavodnik I, Buko V, Lapshyna A, Bryszewska M (2004) Effect of low-intensity (3.75-25 J/cm2) near-infrared (810 nm) laser radiation on red blood cell ATPase activities and membrane structure. J Clin Laser Med Surg 22(2):111-117
29. Katona E, Katona G, Dumitrescu M, Horvath J, Tanos E, Katona L. Membrane effects of the low level infrared laser irradiation, as seen in metabolically intact and impaired human blood cells. Romanian J. Biophys., Vol. 14, Nos. 1-4, P. 99-108
30. Fahimipour F, Nouruzian M, Anvari M, Tafti MA, Yazdi M, Khosravi M, Dehghannayeri Z, Sabounchi SS, Bayat M (2011) Effect of low-level laser therapy on experimental wounds of hard palate mucosa in mice. Indian J Exp Biol 49(5):357-361
31. Benedicenti S, Pepe IM, Angiero F, Benedicenti A (2008) Intracellular ATP level increases in lymphocytes irradiated with infrared laser light of wavelength 904 nm. Photomed Laser Surg 26(5):451-453
32. Karu T (1989) Photobiology of low-power laser effects. Health Phys 56(5):691-704
33. Karu T (1999) Primary and secondary mechanisms of action of visible to near-IR radiation on cells. J Photochem Photobiol B 49(1):1-17
34. Grossman N, Schneid N, Reuveni H, Halevy S, Lubart R (1998) 780 nm low power diode laser irradiation stimulates proliferation of keratinocyte cultures: involvement of reactive oxygen species. Lasers Surg Med 22(4):212-218